Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies specific for CD70 and their uses

Antibodies specific for CD70 and their uses

US Patent 11377500 · Granted Jul 5, 2022

Estimated economic value: $2,433,103,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treatment using anti-CD19 rituximab-resistant chimeric antigen recepto2025
Protease-activating CD45-gate CAR2025
Protease-activating CD45-gate CAR2025
Protease-activating CD45-gate CAR2025
Chimeric antigen receptors targeting FLT32025
Chimeric antigen receptors with enhanced signaling and activities and uses there2025
Chimeric antigen receptors with enhanced signaling and activities and uses there2025
Chimeric antigen receptors with enhanced signaling and activities and uses there2025
Methods of manufacturing allogeneic CAR T cells2024
Inducible chimeric cytokine receptors2024
Chimeric antigen receptors targeting CD702024
Chimeric antigen receptors targeting CD702024